ALPS12
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ALPS12, covering 2026-02-06 to 2026-02-06. Get the full timeline:
Most recent: Clinical Trial Update: A PHASE I STUDY OF ALPS12 IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER [Phase 1]